Visualization of the HIV-1 Env glycan shield across scales

Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28014-28025. doi: 10.1073/pnas.2000260117. Epub 2020 Oct 22.

Abstract

The dense array of N-linked glycans on the HIV-1 envelope glycoprotein (Env), known as the "glycan shield," is a key determinant of immunogenicity, yet intrinsic heterogeneity confounds typical structure-function analysis. Here, we present an integrated approach of single-particle electron cryomicroscopy (cryo-EM), computational modeling, and site-specific mass spectrometry (MS) to probe glycan shield structure and behavior at multiple levels. We found that dynamics lead to an extensive network of interglycan interactions that drive the formation of higher-order structure within the glycan shield. This structure defines diffuse boundaries between buried and exposed protein surface and creates a mapping of potentially immunogenic sites on Env. Analysis of Env expressed in different cell lines revealed how cryo-EM can detect subtle changes in glycan occupancy, composition, and dynamics that impact glycan shield structure and epitope accessibility. Importantly, this identified unforeseen changes in the glycan shield of Env obtained from expression in the same cell line used for vaccine production. Finally, by capturing the enzymatic deglycosylation of Env in a time-resolved manner, we found that highly connected glycan clusters are resistant to digestion and help stabilize the prefusion trimer, suggesting the glycan shield may function beyond immune evasion.

Keywords: HIV-1; cryo-EM; glycoprotein; molecular modeling; vaccine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antibody Formation
  • Computer Simulation
  • Cryoelectron Microscopy / methods
  • Epitopes / chemistry
  • Glycosylation
  • HIV Antibodies / immunology
  • HIV Envelope Protein gp120 / metabolism
  • HIV Seropositivity
  • HIV-1 / immunology*
  • HIV-1 / metabolism
  • Humans
  • Immune Evasion / immunology
  • Mass Spectrometry / methods
  • Models, Molecular
  • Polysaccharides / metabolism*
  • env Gene Products, Human Immunodeficiency Virus / chemistry
  • env Gene Products, Human Immunodeficiency Virus / immunology*

Substances

  • Antibodies, Neutralizing
  • Epitopes
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • Polysaccharides
  • env Gene Products, Human Immunodeficiency Virus